Datum: 30.5.2008
According to findings of a new study published in Nature, tenacious brain tumours called glioblastomas could be easily beated using cytomegaloviruses, common viruses known from immunocompromised patients.
Researchers at Duke University Medical Center have shown in their previous study, that the cytomegalovirus (a type of herpesvirus) is widely presented in glioblastoma cells but not in surrounding healthy tissue. The research team supposed to stop the tumour growth by guiding the immune system to attack the unique antigens of the virus in glioblastoma cells.
They exposed white blood cells from 21 patients to parts of the cytomegalovirus, and injected the cells back into the patients. Their preliminary results suggest that this technique is safe and effective. The researchers hope to develop a new vaccine to treat this type of brain cancer.
Source: http://www.nature.com
CECE 2008
Brno, Czech Republic, November 24-25, 2008
Biotechnology - The Future of Pharmaceutical Industry
Hotel Mariott, Prague, Czech republic, November 25-26, 2008
RNA Club 2008
Institute of Molecular Genetics, Prague, Czech Republic, November 28, 2008
Plant functional genomics and molecular
Novi Sad, Serbia, November 24-27, 2008
Speed and Safety in Drug Discovery
London, UK, November 26, 2008
Biotechnology Havana 2008- AgBiotechnology: facing huge challenges with new approaches
Havana, Cuba, November 30 - Dezember 05, 2008
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Biotechnology links - Useful biotech links for you
Biotechnology Events - Current biotechnology events
Chemists create cancer-detecting nanoparticles
New Biomarker For Heart Failure Identified